These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 9179301)

  • 1. Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein.
    Sticha KR; Sieg CA; Bergstrom CP; Hanna PE; Wagner CR
    Protein Expr Purif; 1997 Jun; 10(1):141-53. PubMed ID: 9179301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
    Wagner CR; Bergstrom CP; Koning KR; Hanna PE
    Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
    Wang H; Vath GM; Kawamura A; Bates CA; Sim E; Hanna PE; Wagner CR
    Protein J; 2005 Feb; 24(2):65-77. PubMed ID: 16003948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hamster monomorphic arylamine N-acetyltransferase: expression in Escherichia coli and purification.
    Bergstrom CP; Wagner CR; Ann DK; Hanna PE
    Protein Expr Purif; 1995 Feb; 6(1):45-55. PubMed ID: 7756838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene.
    Sticha KR; Bergstrom CP; Wagner CR; Hanna PE
    Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
    Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
    Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
    Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
    Cheon HG; Boteju LW; Hanna PE
    Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble expression in Escherichia coli, one-step purification, and characterization of Chinese hamster dihydrofolate reductase.
    Fan YX; Wang B; Jing GZ
    Protein Expr Purif; 1997 Mar; 9(2):246-52. PubMed ID: 9056490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
    Mattano SS; Land S; King CM; Weber WW
    Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein.
    Yu PL; Zhao J; Yu M; Reid R; Santi DV
    Protein Expr Purif; 1996 Aug; 8(1):23-7. PubMed ID: 8812831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential peptide affinity purification system for the systematic isolation and identification of protein complexes from Escherichia coli.
    Babu M; Butland G; Pogoutse O; Li J; Greenblatt JF; Emili A
    Methods Mol Biol; 2009; 564():373-400. PubMed ID: 19544035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-cleavable sortase fusion for one-step purification of free recombinant proteins.
    Mao H
    Protein Expr Purif; 2004 Sep; 37(1):253-63. PubMed ID: 15294306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of active PKB kinase from Escherichia coli.
    Klein S; Geiger T; Linchevski I; Lebendiker M; Itkin A; Assayag K; Levitzki A
    Protein Expr Purif; 2005 May; 41(1):162-9. PubMed ID: 15802234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.
    Russo G; Gast A; Schlaeger EJ; Angiolillo A; Pietropaolo C
    Protein Expr Purif; 1997 Jul; 10(2):214-25. PubMed ID: 9226718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and affinity purification of a novel, biologically active, CNTF fusion protein.
    Rabinovsky ED; Browder DP; McManaman JL
    J Neurosci Res; 1994 Jun; 38(2):127-33. PubMed ID: 8078097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of dihydrofolate reductase affinity handle in expressing human prolactin as a soluble fusion protein.
    Iwakura M; Morikawa M
    Biosci Biotechnol Biochem; 1993 Nov; 57(11):1955-7. PubMed ID: 7764341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.
    Tsukamoto H; Fukudome K; Kohara J; Nakatake H; Kimoto M
    Protein Expr Purif; 2007 Nov; 56(1):138-44. PubMed ID: 17703948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.